GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 54.33 | -44.26 | 17.00 | 52.46 | 50.10 |
What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 54.33 |
| Mar2024 | -44.26 |
| Mar2023 | 17.00 |
| Mar2022 | 52.46 |
| Mar2021 | 50.10 |
How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 54.33 | Positive | |
| Mar2024 | -44.26 | Negative | |
| Mar2023 | 17 | -67.59 | |
| Mar2022 | 52.46 | 4.71 | |
| Mar2021 | 50.1 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹66,047.5 Cr | 3.8% | 4% | 64.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.8% |
4% |
64.1% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses